Eyes On The Money
Disclaimer: All content on this site is provided for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. The analyses and strategies presented here are personal musings and opinions. You are solely responsible for any investment decisions you make. Investing involves risk of loss, and past performance does not guarantee future results. Consult a qualified financial advisor before making investment decisions. AI was used in the generation of these reports.
Previous All reports (083650.KQ) Next

BHI (083650): Reversal Rejected — the Bounce Was Distribution

083650.KQ update 한국어로 보기

BHI (083650): Reversal Rejected — the Bounce Was Distribution

As of 2026-08-07 close (₩49,900). Follow-up to the 2026-07-24, 07-19 and 06-29 notes.

The prior six-article sequence on BHI was consistently, correctly bearish — "no entry" through the entire decline from ₩114,200. This update resolves the open question left by the 7/24 piece ("Dead Cat Bounce or Reversal?"): the +53% bounce off the ₩33,150 low is a foreign-distribution event, not a reversal. The accumulation thesis that underpinned the bull case is now dead by the series' own criteria.

The bounce, and who drove it

From the 7/30 low (₩34,600 close, ₩33,150 intraday) BHI ran +53% to ₩53,100 on 8/06, then reversed −6% to ₩49,900 on 8/07 — stalling right at the 50-day MA (₩54,216) and rejecting. The move was institutional buying absorbed almost entirely by foreign selling:

Date Close Chg% Inst Net Frgn Net Retail Frgn %
7/31 40,300 +16.5% +31,847 −5,425 −26,422 13.58%
8/03 42,650 +5.8% +28,702 −33,406 +4,704 13.49%
8/04 49,850 +16.9% +157,410 −158,943 +1,533 13.02%
8/05 50,500 +1.3% +36,053 −61,121 +25,068 12.67%
8/06 53,100 +5.2% +60,962 −48,090 −12,872 12.32%
8/07 49,900 −6.0% −14,081 −57,928 +72,009 12.13%

Over 7/20–8/07 institutions bought a net +395k shares while foreign sold −430k. The 8/04 breakout is the tell: a near-perfect handoff (Inst +157k / Frgn −159k) on the highest volume of the move — a distribution day dressed as a breakout. Foreign ownership fell 15.00% → 12.13% in three weeks (~890k shares, ~19% of the foreign stake). The 8/07 reversal added the warning: −6% with foreign still selling while retail bought +72k — retail is now the marginal buyer at the top of the bounce.

Why now — the earnings clock, and why it is not an insider signal

BHI's H1 report (반기보고서) is due about August 14, its statutory filing deadline (DART cadence: Q1 filed 5/15; last year's H1 filed 8/14). That timing invites a tempting read — that the bounce is smart money front-running good numbers. The disclosure and flow record says otherwise.

Read plainly: this is positioning into a known date with the informed cohorts split and no numbers released — foreign taking liquidity, domestic institutions providing it, and retail buying the rollover. It is not evidence of a good outcome leaking out; it is a contested, event-driven tape whose result nobody yet knows.

The prior framework was vindicated on every level

The bear sequence was unusually well-calibrated. Every downside reference was hit in order, and every flow-negation level fired:

The 7/19 note pre-described this exact rally as "a bear-market rally until proven otherwise." It arrived without foreign confirmation — the proof never came.

Valuation, recomputed on FY2025

FY2025 (ended 2025-12-31) was a genuine step-change: revenue ₩774.1B (+91% YoY), operating income ₩75.5B (+244%), net income ₩65.2B (+233%), diluted EPS ₩2,107 on 30.94M shares. Earnings tripled while the stock fell 71% — the de-rating is real.

But the clean multiple is higher than the headline suggests. FY2025 net income includes +₩9.35B of unusual gains; normalized income is ₩57.5B (EPS ~₩1,859):

At ~27× normalized, the market is not treating ₩65B as a repeatable run-rate — and it shouldn't. The ₩774B revenue is a lumpy, project-delivery peak (accounts payable ballooned to ₩322B, working capital −₩82B, current debt ₩144B). Paying ~27× for possibly-peak earnings, into foreign distribution, is the bear case in one line.

The value anchor is unchanged from the 7/19 note: 11× normalized EPS ≈ ₩20,450 — the level where the thesis stops depending on the revenue-doubling repeating. Current ₩49,900 is ~2.4× that.

Bottom line

The reversal question is answered: this was distribution, not a base. Foreign is exiting, ownership is in freefall, the bounce died at the 50-day, and the stock is expensive (~27× normalized) on earnings that lean on a peak revenue year and one-off gains. The ~8/14 H1 report is the near-term binary — and foreign selling into it, with retail buying, is a caution flag, not a green light: nobody has the numbers yet. There is no entry here. The read flips only two ways — a flow-confirmed reclaim of the 50-day, or a decline into the ₩20k value zone — and nothing in between deserves capital.

Buy Strategy

Disclaimer: The strategy below represents personal musings and opinions, not investment advice. You are solely responsible for any trading decisions you make.
  • No entry at ₩49,900. You would be paying ~27× normalized earnings into persistent foreign selling — the exact setup the prior six notes correctly refused.
  • Do not read the pre-earnings bounce as informed accumulation. The H1 numbers are not out, and the informed cohorts are split — foreign selling hard while domestic institutions buy — not the unified buying a good-news leak would produce. Wait for the print rather than guessing its direction.
  • Momentum probe — requires BOTH: (1) foreign flips to net buyer for 2–3 consecutive sessions with ownership turning up from ~12%, and (2) price reclaims and holds the 50-day (~₩54,200). Only then a small probe, sized for a stock still below its 200-day (₩67,903).
  • Value accumulation zone ~₩20,000–20,500 (11× normalized FY2025 EPS). This is where the value case no longer needs the growth scenario. A controlled approach that holds is the asymmetric long, independent of flow confirmation.
  • Do not average on price alone between ₩49,900 and ₩20,000. Two distinct entries only — the flow-confirmed 50-day reclaim, or the ₩20k value level — the middle is no-man's-land.

Sell Strategy

Disclaimer: The strategy below represents personal musings and opinions, not investment advice. You are solely responsible for any trading decisions you make.
  • Sell into this strength. The bounce is distribution; ₩48,100–49,000 is the prior invalidation-turned-resistance where price sits now, and the 50-day (~₩54,200) is the next ceiling. Reduce while foreign sells.
  • Near-term event risk — the ~8/14 H1 report. Foreign is distributing into a known catalyst while retail absorbs it. Treat the print as a binary with the numbers still unreleased; a post-report gap in either direction is on the table, and the pre-earnings run is not evidence of a good outcome.
  • Hard invalidation / stop: a decisive close below ₩34,000 (7/30 low ₩34,600 / 52-week intraday ₩33,150) reopens the downtrend with no framework support until the ₩20k value zone.
  • Earnings-quality watch: if the H1 report shows revenue mean-reverting from the ₩774B peak, the normalized multiple re-inflates and the value anchor should be lowered accordingly.
  • Foreign flow is the master switch: ownership breaking below ~12% or foreign selling re-accelerating means stay out regardless of any price bounce.